Abstract
Future MicrobiologyAhead of Print CommentaryClostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?Aleksandra M Kubiak, Jella van de Laak, Yanchao Zhang, Tom S Bailey, Luuk Claessen, Philip Hittmeyer, Carlijn Vlaswinkel, Alexsandra Mowday, Ludwig J Dubois & Jan TheysAleksandra M Kubiak https://orcid.org/0000-0002-0737-8618Department of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsExomnis Biotech BV, Maastricht, 6229 EV, The NetherlandsSearch for more papers by this author, Jella van de LaakDepartment of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsSearch for more papers by this author, Yanchao ZhangDepartment of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsSearch for more papers by this author, Tom S BaileyDepartment of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsSearch for more papers by this author, Luuk ClaessenDepartment of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsSearch for more papers by this author, Philip HittmeyerDepartment of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsSearch for more papers by this author, Carlijn VlaswinkelDepartment of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsSearch for more papers by this author, Alexsandra Mowday https://orcid.org/0000-0001-7480-9580Auckland Cancer Society Research Centre, University of Auckland, Auckland, 1023, New ZealandSearch for more papers by this author, Ludwig J Dubois https://orcid.org/0000-0002-8887-4137Department of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsSearch for more papers by this author & Jan Theys *Author for correspondence: E-mail Address: jan.theys@maastrichtuniversity.nlhttps://orcid.org/0000-0002-9718-8251Department of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200 MD,The NetherlandsSearch for more papers by this authorPublished Online:23 May 2023https://doi.org/10.2217/fmb-2022-0220AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: biotherapeuticsClostridiumengineeringpreventiontreatmentPapers of special note have been highlighted as: • of interest; •• of considerable interest
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
